

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.27242351 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.74766524 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.74766524 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.62652442 |
| 5 | * NIK/NF-kappaB signaling (GO:0038061) | 5.14513699 |
| 6 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.08686117 |
| 7 | negative thymic T cell selection (GO:0045060) | 5.06191241 |
| 8 | negative T cell selection (GO:0043383) | 5.03184487 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.96314576 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.96314576 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.96314576 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.96314576 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.96314576 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.96314576 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.84580477 |
| 16 | positive thymic T cell selection (GO:0045059) | 4.62463014 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 4.60477663 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 4.54741572 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.49205028 |
| 20 | response to muramyl dipeptide (GO:0032495) | 4.32321037 |
| 21 | thymic T cell selection (GO:0045061) | 4.25431220 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.17508615 |
| 23 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.17016231 |
| 24 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.15178072 |
| 25 | response to interleukin-15 (GO:0070672) | 4.13958957 |
| 26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.08200278 |
| 27 | negative regulation of cell killing (GO:0031342) | 4.08200278 |
| 28 | detection of bacterium (GO:0016045) | 4.03648466 |
| 29 | T cell selection (GO:0045058) | 4.02813565 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.00723555 |
| 31 | regulation of T cell tolerance induction (GO:0002664) | 4.00571209 |
| 32 | cellular response to interleukin-15 (GO:0071350) | 3.99917973 |
| 33 | positive regulation of antigen processing and presentation (GO:0002579) | 3.95232634 |
| 34 | detection of other organism (GO:0098543) | 3.91580963 |
| 35 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.91143883 |
| 36 | interferon-gamma production (GO:0032609) | 3.89726494 |
| 37 | positive T cell selection (GO:0043368) | 3.88513016 |
| 38 | positive regulation of interleukin-2 production (GO:0032743) | 3.86633967 |
| 39 | myeloid dendritic cell differentiation (GO:0043011) | 3.84121944 |
| 40 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.82824556 |
| 41 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.80740257 |
| 42 | T cell migration (GO:0072678) | 3.79545676 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.69066239 |
| 44 | positive regulation of interleukin-12 production (GO:0032735) | 3.68833804 |
| 45 | myeloid dendritic cell activation (GO:0001773) | 3.67414101 |
| 46 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.65903242 |
| 47 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.62101799 |
| 48 | tolerance induction (GO:0002507) | 3.60702709 |
| 49 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.60518883 |
| 50 | response to type I interferon (GO:0034340) | 3.59062891 |
| 51 | cellular response to type I interferon (GO:0071357) | 3.56529430 |
| 52 | type I interferon signaling pathway (GO:0060337) | 3.56529430 |
| 53 | regulation of memory T cell differentiation (GO:0043380) | 3.50492137 |
| 54 | regulation of antigen processing and presentation (GO:0002577) | 3.49090389 |
| 55 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.48953562 |
| 56 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.48110811 |
| 57 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.46643500 |
| 58 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.44409147 |
| 59 | positive regulation of B cell differentiation (GO:0045579) | 3.43699104 |
| 60 | B cell homeostasis (GO:0001782) | 3.41057187 |
| 61 | growth hormone receptor signaling pathway (GO:0060396) | 3.39979705 |
| 62 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.38485971 |
| 63 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.38485971 |
| 64 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.37207310 |
| 65 | regulation of response to interferon-gamma (GO:0060330) | 3.35052036 |
| 66 | regulation of B cell differentiation (GO:0045577) | 3.33571250 |
| 67 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.33416314 |
| 68 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.32536200 |
| 69 | positive regulation of interferon-alpha production (GO:0032727) | 3.26327937 |
| 70 | negative regulation of T cell mediated immunity (GO:0002710) | 3.26085368 |
| 71 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.25777610 |
| 72 | germinal center formation (GO:0002467) | 3.24393721 |
| 73 | response to protozoan (GO:0001562) | 3.21427632 |
| 74 | B cell receptor signaling pathway (GO:0050853) | 3.18710668 |
| 75 | leukocyte aggregation (GO:0070486) | 3.17348109 |
| 76 | immunoglobulin mediated immune response (GO:0016064) | 3.17309192 |
| 77 | regulation of interleukin-12 production (GO:0032655) | 3.16342861 |
| 78 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.16320012 |
| 79 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.16312246 |
| 80 | response to host immune response (GO:0052572) | 3.16312246 |
| 81 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.15720532 |
| 82 | positive regulation of humoral immune response (GO:0002922) | 3.15487899 |
| 83 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.13829819 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.12931180 |
| 85 | response to host (GO:0075136) | 3.12271008 |
| 86 | response to host defenses (GO:0052200) | 3.12271008 |
| 87 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.12271008 |
| 88 | negative regulation of interleukin-12 production (GO:0032695) | 3.10426735 |
| 89 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.10337372 |
| 90 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09470499 |
| 91 | dendritic cell differentiation (GO:0097028) | 3.09233363 |
| 92 | regulation of interferon-alpha production (GO:0032647) | 3.08765991 |
| 93 | natural killer cell activation (GO:0030101) | 3.05674410 |
| 94 | neutrophil activation (GO:0042119) | 3.05509624 |
| 95 | response to peptidoglycan (GO:0032494) | 3.05197049 |
| 96 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.04424611 |
| 97 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.03148597 |
| 98 | B cell mediated immunity (GO:0019724) | 3.02773931 |
| 99 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.01705410 |
| 100 | T-helper cell differentiation (GO:0042093) | 3.01705410 |
| 101 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.99238145 |
| 102 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.98630138 |
| 103 | positive regulation of isotype switching (GO:0045830) | 2.97754263 |
| 104 | myeloid cell activation involved in immune response (GO:0002275) | 2.96009246 |
| 105 | T-helper 1 type immune response (GO:0042088) | 2.95220525 |
| 106 | regulation of tolerance induction (GO:0002643) | 2.93777695 |
| 107 | detection of external biotic stimulus (GO:0098581) | 2.93663050 |
| 108 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93290223 |
| 109 | granulocyte activation (GO:0036230) | 2.92285734 |
| 110 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.92278389 |
| 111 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.91221750 |
| 112 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.91109783 |
| 113 | * T cell costimulation (GO:0031295) | 2.89545360 |
| 114 | regulation of regulatory T cell differentiation (GO:0045589) | 2.89155662 |
| 115 | neutrophil activation involved in immune response (GO:0002283) | 2.88961311 |
| 116 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.88832249 |
| 117 | cellular response to growth hormone stimulus (GO:0071378) | 2.88824845 |
| 118 | mature B cell differentiation (GO:0002335) | 2.88056177 |
| 119 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.87727011 |
| 120 | regulation of interleukin-2 production (GO:0032663) | 2.87641095 |
| 121 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.86809004 |
| 122 | negative regulation of innate immune response (GO:0045824) | 2.86226671 |
| 123 | regulation of T-helper cell differentiation (GO:0045622) | 2.84699920 |
| 124 | T cell receptor signaling pathway (GO:0050852) | 2.84685503 |
| 125 | positive regulation of type 2 immune response (GO:0002830) | 2.84135924 |
| 126 | lymphocyte migration (GO:0072676) | 2.83874941 |
| 127 | positive regulation of T cell differentiation (GO:0045582) | 2.83651384 |
| 128 | natural killer cell differentiation (GO:0001779) | 2.83147304 |
| 129 | * lymphocyte costimulation (GO:0031294) | 2.83079209 |
| 130 | positive regulation of natural killer cell activation (GO:0032816) | 2.83067036 |
| 131 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.82735251 |
| 132 | activated T cell proliferation (GO:0050798) | 2.82729196 |
| 133 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.82225054 |
| 134 | lymphocyte homeostasis (GO:0002260) | 2.82129133 |
| 135 | regulation of cell killing (GO:0031341) | 2.82098215 |
| 136 | regulation of RIG-I signaling pathway (GO:0039535) | 2.81933454 |
| 137 | defense response to protozoan (GO:0042832) | 2.80280579 |
| 138 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.80277392 |
| 139 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.80277392 |
| 140 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.79084749 |
| 141 | JAK-STAT cascade (GO:0007259) | 2.76869961 |
| 142 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.76194932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.20814040 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.86803285 |
| 3 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.25590497 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.15144749 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.99982546 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.66061213 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.60018573 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.34153794 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.30745336 |
| 10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.22565070 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.14942585 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.05203278 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03000882 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.96685076 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.90717130 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.87678452 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.84519091 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.82518076 |
| 19 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76579491 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.67177846 |
| 21 | * MYB_26560356_Chip-Seq_TH2_Human | 2.60864787 |
| 22 | * MAF_26560356_Chip-Seq_TH1_Human | 2.53194299 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.47454381 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.34818865 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33397926 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32944676 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.27553621 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.17096803 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.11219681 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.04837582 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 2.04348889 |
| 32 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.99431098 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95527196 |
| 34 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.93508820 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.91949439 |
| 36 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91539237 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.83184896 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82089088 |
| 39 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.81026207 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77819351 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.77726128 |
| 42 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.77617204 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74976956 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.69880372 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69822758 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65790508 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.62478314 |
| 48 | * MAF_26560356_Chip-Seq_TH2_Human | 1.59531806 |
| 49 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.57327957 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56177407 |
| 51 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.55722435 |
| 52 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.55263070 |
| 53 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.53768430 |
| 54 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.51318797 |
| 55 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.49176227 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48694896 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.47506013 |
| 58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43038061 |
| 59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41685823 |
| 60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40451994 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35523476 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35471315 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30634559 |
| 64 | * P68_20966046_ChIP-Seq_HELA_Human | 1.26096203 |
| 65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24435989 |
| 66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19878799 |
| 67 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19491165 |
| 68 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17487164 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15991470 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15404023 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13239615 |
| 72 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10333540 |
| 73 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.09980265 |
| 74 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09317408 |
| 75 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.08681903 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08617839 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08383607 |
| 78 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.08209552 |
| 79 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07718777 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06309124 |
| 81 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05540410 |
| 82 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05320785 |
| 83 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04063621 |
| 84 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03324133 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02731550 |
| 86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02400640 |
| 87 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02359454 |
| 88 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02270136 |
| 89 | P300_27268052_Chip-Seq_Bcells_Human | 1.02202037 |
| 90 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99347064 |
| 91 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98283651 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98209275 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97907220 |
| 94 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97593932 |
| 95 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97460930 |
| 96 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.97433831 |
| 97 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97156706 |
| 98 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.95577523 |
| 99 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94890186 |
| 100 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94468995 |
| 101 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94360873 |
| 102 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.90659517 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85790626 |
| 104 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84019860 |
| 105 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83385014 |
| 106 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80304245 |
| 107 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.78625712 |
| 108 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.78311107 |
| 109 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77401810 |
| 110 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76596737 |
| 111 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76226857 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74757469 |
| 113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74151801 |
| 114 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73978221 |
| 115 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.72979672 |
| 116 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.72965927 |
| 117 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72574451 |
| 118 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72510445 |
| 119 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72063281 |
| 120 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.71890398 |
| 121 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.71890398 |
| 122 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70758883 |
| 123 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.69606571 |
| 124 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67214462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 4.39135515 |
| 2 | * MP0000685_abnormal_immune_system | 3.86159973 |
| 3 | MP0004510_myositis | 3.47782310 |
| 4 | * MP0001790_abnormal_immune_system | 3.37670204 |
| 5 | * MP0005387_immune_system_phenotype | 3.37670204 |
| 6 | * MP0001800_abnormal_humoral_immune | 3.16970152 |
| 7 | * MP0005671_abnormal_response_to | 3.06754350 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.06489150 |
| 9 | MP0003436_decreased_susceptibility_to | 2.92861109 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.89680150 |
| 11 | * MP0002452_abnormal_antigen_presenting | 2.78363262 |
| 12 | MP0009785_altered_susceptibility_to | 2.70768928 |
| 13 | * MP0002723_abnormal_immune_serum | 2.67911462 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.61195017 |
| 15 | * MP0001819_abnormal_immune_cell | 2.50499289 |
| 16 | * MP0002420_abnormal_adaptive_immunity | 2.49620050 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.48927886 |
| 18 | * MP0005025_abnormal_response_to | 2.45082960 |
| 19 | MP0003303_peritoneal_inflammation | 2.40920789 |
| 20 | MP0001873_stomach_inflammation | 2.35046338 |
| 21 | MP0002419_abnormal_innate_immunity | 2.31563866 |
| 22 | MP0005310_abnormal_salivary_gland | 2.22561403 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.20826429 |
| 24 | MP0001853_heart_inflammation | 2.19948827 |
| 25 | * MP0002398_abnormal_bone_marrow | 2.18928474 |
| 26 | MP0002254_reproductive_system_inflammat | 2.16059961 |
| 27 | * MP0002405_respiratory_system_inflammati | 2.14048489 |
| 28 | * MP0002138_abnormal_hepatobiliary_system | 2.09183537 |
| 29 | * MP0000716_abnormal_immune_system | 2.08750285 |
| 30 | MP0010155_abnormal_intestine_physiology | 2.01677299 |
| 31 | MP0003724_increased_susceptibility_to | 1.99553081 |
| 32 | MP0002006_tumorigenesis | 1.98792332 |
| 33 | MP0006082_CNS_inflammation | 1.97872150 |
| 34 | MP0004947_skin_inflammation | 1.97625179 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.81361100 |
| 36 | * MP0000689_abnormal_spleen_morphology | 1.74179359 |
| 37 | * MP0002722_abnormal_immune_system | 1.72935186 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.70109360 |
| 39 | * MP0001845_abnormal_inflammatory_respons | 1.69316340 |
| 40 | * MP0002429_abnormal_blood_cell | 1.64561796 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.64380472 |
| 42 | MP0005451_abnormal_body_composition | 1.62778883 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.58760851 |
| 44 | * MP0000703_abnormal_thymus_morphology | 1.56766772 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.54036883 |
| 46 | MP0003866_abnormal_defecation | 1.49568354 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.41437001 |
| 48 | MP0002933_joint_inflammation | 1.36611414 |
| 49 | MP0009840_abnormal_foam_cell | 1.36442872 |
| 50 | MP0009278_abnormal_bone_marrow | 1.35514102 |
| 51 | MP0003448_altered_tumor_morphology | 1.34147593 |
| 52 | MP0000858_altered_metastatic_potential | 1.28736670 |
| 53 | MP0004381_abnormal_hair_follicle | 1.27339129 |
| 54 | MP0010352_gastrointestinal_tract_polyps | 1.25521663 |
| 55 | MP0002163_abnormal_gland_morphology | 1.21067224 |
| 56 | * MP0008469_abnormal_protein_level | 1.20809129 |
| 57 | MP0003045_fibrosis | 1.17621030 |
| 58 | MP0008260_abnormal_autophagy | 1.15905066 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.15645282 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.15645282 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.13204272 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.12401797 |
| 63 | MP0003091_abnormal_cell_migration | 1.11227490 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 1.11037718 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.10744190 |
| 66 | MP0009764_decreased_sensitivity_to | 1.09880229 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.09152857 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.08907502 |
| 69 | MP0001663_abnormal_digestive_system | 1.05655196 |
| 70 | MP0005174_abnormal_tail_pigmentation | 1.04465352 |
| 71 | * MP0001348_abnormal_lacrimal_gland | 1.01543093 |
| 72 | MP0002877_abnormal_melanocyte_morpholog | 0.98213356 |
| 73 | MP0001851_eye_inflammation | 0.96386834 |
| 74 | MP0008057_abnormal_DNA_replication | 0.95357953 |
| 75 | MP0005058_abnormal_lysosome_morphology | 0.90777446 |
| 76 | MP0003828_pulmonary_edema | 0.89540870 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.88179461 |
| 78 | MP0000015_abnormal_ear_pigmentation | 0.87494159 |
| 79 | MP0005166_decreased_susceptibility_to | 0.83924709 |
| 80 | MP0002139_abnormal_hepatobiliary_system | 0.82018641 |
| 81 | MP0002009_preneoplasia | 0.81750971 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 0.81102422 |
| 83 | MP0010307_abnormal_tumor_latency | 0.81003429 |
| 84 | MP0000490_abnormal_crypts_of | 0.80144786 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.79230831 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.77660940 |
| 87 | * MP0002928_abnormal_bile_duct | 0.75252944 |
| 88 | MP0000733_abnormal_muscle_development | 0.72391448 |
| 89 | MP0005390_skeleton_phenotype | 0.71948257 |
| 90 | MP0005023_abnormal_wound_healing | 0.71573208 |
| 91 | MP0001881_abnormal_mammary_gland | 0.70880237 |
| 92 | MP0009115_abnormal_fat_cell | 0.70300041 |
| 93 | MP0000249_abnormal_blood_vessel | 0.69827179 |
| 94 | MP0004130_abnormal_muscle_cell | 0.68498879 |
| 95 | MP0003075_altered_response_to | 0.66947274 |
| 96 | MP0009763_increased_sensitivity_to | 0.66204846 |
| 97 | MP0002019_abnormal_tumor_incidence | 0.66096514 |
| 98 | * MP0002136_abnormal_kidney_physiology | 0.62785054 |
| 99 | MP0005360_urolithiasis | 0.62741795 |
| 100 | MP0001346_abnormal_lacrimal_gland | 0.62443422 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.61397986 |
| 102 | * MP0002693_abnormal_pancreas_physiology | 0.61134134 |
| 103 | MP0005381_digestive/alimentary_phenotyp | 0.60441235 |
| 104 | MP0002132_abnormal_respiratory_system | 0.59684720 |
| 105 | MP0000767_abnormal_smooth_muscle | 0.59344177 |
| 106 | MP0001958_emphysema | 0.59267082 |
| 107 | MP0003795_abnormal_bone_structure | 0.57801408 |
| 108 | MP0008874_decreased_physiological_sensi | 0.57162333 |
| 109 | MP0003191_abnormal_cellular_cholesterol | 0.56795104 |
| 110 | * MP0000609_abnormal_liver_physiology | 0.56436238 |
| 111 | MP0010234_abnormal_vibrissa_follicle | 0.55988785 |
| 112 | MP0001216_abnormal_epidermal_layer | 0.54728836 |
| 113 | MP0000343_altered_response_to | 0.54385517 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.53940425 |
| 115 | MP0000604_amyloidosis | 0.53642930 |
| 116 | MP0008007_abnormal_cellular_replicative | 0.53353500 |
| 117 | MP0005083_abnormal_biliary_tract | 0.52655343 |
| 118 | MP0004883_abnormal_blood_vessel | 0.50568477 |
| 119 | MP0005075_abnormal_melanosome_morpholog | 0.49580601 |
| 120 | MP0000371_diluted_coat_color | 0.48762863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.32773778 |
| 2 | Recurrent fungal infections (HP:0002841) | 4.96584967 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.87808231 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.41511360 |
| 5 | Chronic otitis media (HP:0000389) | 4.39381950 |
| 6 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.32482295 |
| 7 | Recurrent cutaneous fungal infections (HP:0011370) | 4.32482295 |
| 8 | Myositis (HP:0100614) | 4.30732107 |
| 9 | Recurrent viral infections (HP:0004429) | 4.29282349 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.15952897 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.14004848 |
| 12 | Optic neuritis (HP:0100653) | 4.02285389 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 4.02285389 |
| 14 | Orchitis (HP:0100796) | 3.89314083 |
| 15 | Recurrent bronchitis (HP:0002837) | 3.85587245 |
| 16 | Recurrent skin infections (HP:0001581) | 3.74283064 |
| 17 | Nasal polyposis (HP:0100582) | 3.70399632 |
| 18 | Abnormality of T cell number (HP:0011839) | 3.64120048 |
| 19 | Agammaglobulinemia (HP:0004432) | 3.61975343 |
| 20 | Vasculitis (HP:0002633) | 3.61009305 |
| 21 | T lymphocytopenia (HP:0005403) | 3.50276293 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.45996556 |
| 23 | Increased IgE level (HP:0003212) | 3.42194865 |
| 24 | Colitis (HP:0002583) | 3.41467712 |
| 25 | Stomatitis (HP:0010280) | 3.40043292 |
| 26 | Inflammation of the large intestine (HP:0002037) | 3.38968944 |
| 27 | Panhypogammaglobulinemia (HP:0003139) | 3.38431889 |
| 28 | IgM deficiency (HP:0002850) | 3.37272306 |
| 29 | Meningitis (HP:0001287) | 3.35384096 |
| 30 | Cellulitis (HP:0100658) | 3.23598818 |
| 31 | Abnormality of the nasal mucosa (HP:0000433) | 3.22866038 |
| 32 | Abnormality of the fingertips (HP:0001211) | 3.18121394 |
| 33 | Arterial thrombosis (HP:0004420) | 3.16590161 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 3.16583872 |
| 35 | Pulmonary infiltrates (HP:0002113) | 3.12518488 |
| 36 | Abnormality of T cells (HP:0002843) | 3.06752321 |
| 37 | Emphysema (HP:0002097) | 2.97759625 |
| 38 | Gastrointestinal stroma tumor (HP:0100723) | 2.96164946 |
| 39 | Thrombocytosis (HP:0001894) | 2.88122904 |
| 40 | Gingivitis (HP:0000230) | 2.87867002 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 2.86576420 |
| 42 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.83070494 |
| 43 | Lymphopenia (HP:0001888) | 2.82870614 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.82034620 |
| 45 | Eosinophilia (HP:0001880) | 2.78510350 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 2.78376364 |
| 47 | Hemoptysis (HP:0002105) | 2.75920056 |
| 48 | Chronic diarrhea (HP:0002028) | 2.75233501 |
| 49 | Abnormality of T cell physiology (HP:0011840) | 2.74018646 |
| 50 | Abnormality of macrophages (HP:0004311) | 2.72777873 |
| 51 | Chronic sinusitis (HP:0011109) | 2.68545431 |
| 52 | Leukocytosis (HP:0001974) | 2.67602400 |
| 53 | Gastrointestinal infarctions (HP:0005244) | 2.58939810 |
| 54 | Persistence of primary teeth (HP:0006335) | 2.58920184 |
| 55 | Myocardial infarction (HP:0001658) | 2.57651861 |
| 56 | Urticaria (HP:0001025) | 2.57599396 |
| 57 | IgG deficiency (HP:0004315) | 2.57445653 |
| 58 | Abnormality of eosinophils (HP:0001879) | 2.56288982 |
| 59 | Keratoconjunctivitis (HP:0001096) | 2.55679100 |
| 60 | Hypergammaglobulinemia (HP:0010702) | 2.52002763 |
| 61 | Keratoconjunctivitis sicca (HP:0001097) | 2.50222150 |
| 62 | IgA deficiency (HP:0002720) | 2.49912832 |
| 63 | Periodontitis (HP:0000704) | 2.49870504 |
| 64 | Hematochezia (HP:0002573) | 2.48826771 |
| 65 | Obstructive lung disease (HP:0006536) | 2.47553262 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 2.47553262 |
| 67 | Osteomyelitis (HP:0002754) | 2.45788400 |
| 68 | Gingival bleeding (HP:0000225) | 2.45785569 |
| 69 | Spontaneous hematomas (HP:0007420) | 2.44549881 |
| 70 | Fatigue (HP:0012378) | 2.43673049 |
| 71 | Pustule (HP:0200039) | 2.43274484 |
| 72 | Encephalitis (HP:0002383) | 2.42065059 |
| 73 | Increased IgM level (HP:0003496) | 2.41328558 |
| 74 | Thyroiditis (HP:0100646) | 2.40652528 |
| 75 | Increased density of long bones (HP:0006392) | 2.39500608 |
| 76 | Chest pain (HP:0100749) | 2.35693093 |
| 77 | Severe combined immunodeficiency (HP:0004430) | 2.34057906 |
| 78 | Joint swelling (HP:0001386) | 2.32688387 |
| 79 | Granulocytopenia (HP:0001913) | 2.31721423 |
| 80 | Verrucae (HP:0200043) | 2.31031628 |
| 81 | Papilloma (HP:0012740) | 2.31031628 |
| 82 | Hypochromic anemia (HP:0001931) | 2.27078580 |
| 83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.22398693 |
| 84 | Spinal cord lesions (HP:0100561) | 2.22186312 |
| 85 | Syringomyelia (HP:0003396) | 2.22186312 |
| 86 | Severe visual impairment (HP:0001141) | 2.19614184 |
| 87 | Malnutrition (HP:0004395) | 2.16201652 |
| 88 | Prolonged bleeding time (HP:0003010) | 2.14321863 |
| 89 | Slow saccadic eye movements (HP:0000514) | 2.13493272 |
| 90 | Recurrent sinusitis (HP:0011108) | 2.13406812 |
| 91 | Hypertensive crisis (HP:0100735) | 2.12224980 |
| 92 | Increased cerebral lipofuscin (HP:0011813) | 2.11930546 |
| 93 | Skin ulcer (HP:0200042) | 2.11026799 |
| 94 | Sepsis (HP:0100806) | 2.08926611 |
| 95 | Combined immunodeficiency (HP:0005387) | 2.08445504 |
| 96 | Viral hepatitis (HP:0006562) | 2.04962835 |
| 97 | Cheilitis (HP:0100825) | 2.04917466 |
| 98 | Restrictive lung disease (HP:0002091) | 2.02828593 |
| 99 | Global brain atrophy (HP:0002283) | 2.02422627 |
| 100 | Recurrent pneumonia (HP:0006532) | 2.02266848 |
| 101 | Epistaxis (HP:0000421) | 2.01450274 |
| 102 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01392627 |
| 103 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.01193963 |
| 104 | B lymphocytopenia (HP:0010976) | 1.98311677 |
| 105 | Abnormality of B cell number (HP:0010975) | 1.98311677 |
| 106 | Skin rash (HP:0000988) | 1.97127903 |
| 107 | Abnormality of the pleura (HP:0002103) | 1.95913458 |
| 108 | Bronchitis (HP:0012387) | 1.95417799 |
| 109 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95055886 |
| 110 | Dysostosis multiplex (HP:0000943) | 1.95008749 |
| 111 | Arthralgia (HP:0002829) | 1.93412586 |
| 112 | Papilledema (HP:0001085) | 1.92819708 |
| 113 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91218232 |
| 114 | Spondylolisthesis (HP:0003302) | 1.86460158 |
| 115 | Acrocyanosis (HP:0001063) | 1.84743025 |
| 116 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.84542717 |
| 117 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.84542717 |
| 118 | Abnormality of glycolipid metabolism (HP:0010969) | 1.84542717 |
| 119 | Absent frontal sinuses (HP:0002688) | 1.84451403 |
| 120 | Basal ganglia calcification (HP:0002135) | 1.84326163 |
| 121 | Loss of speech (HP:0002371) | 1.84001004 |
| 122 | Asymmetric septal hypertrophy (HP:0001670) | 1.83857927 |
| 123 | Leukopenia (HP:0001882) | 1.83606617 |
| 124 | Autoimmune hemolytic anemia (HP:0001890) | 1.82492138 |
| 125 | Lymphoma (HP:0002665) | 1.82322896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.42426117 |
| 2 | MAP4K1 | 4.15007501 |
| 3 | TYK2 | 3.41827242 |
| 4 | JAK3 | 3.35719527 |
| 5 | PRPF4B | 2.77162165 |
| 6 | IKBKB | 2.63929835 |
| 7 | TXK | 2.63558311 |
| 8 | TBK1 | 2.61301021 |
| 9 | JAK1 | 2.50071009 |
| 10 | IKBKE | 2.48393370 |
| 11 | FGFR4 | 2.31445855 |
| 12 | IRAK3 | 2.28521903 |
| 13 | NLK | 2.25133082 |
| 14 | CHUK | 2.19566154 |
| 15 | EPHB1 | 2.07800257 |
| 16 | CDK12 | 1.91957226 |
| 17 | EPHA3 | 1.90945129 |
| 18 | ZAP70 | 1.90663558 |
| 19 | BLK | 1.89533120 |
| 20 | IRAK4 | 1.84104981 |
| 21 | MAP3K13 | 1.81135163 |
| 22 | ITK | 1.74383771 |
| 23 | MAP3K10 | 1.68710206 |
| 24 | STK10 | 1.62582895 |
| 25 | BTK | 1.62097482 |
| 26 | GRK6 | 1.61299769 |
| 27 | KIT | 1.55843993 |
| 28 | FGFR3 | 1.48220997 |
| 29 | TGFBR2 | 1.45588131 |
| 30 | MAP3K11 | 1.40770203 |
| 31 | SYK | 1.39807360 |
| 32 | PIM1 | 1.35854332 |
| 33 | CSF1R | 1.34472606 |
| 34 | TEC | 1.33322764 |
| 35 | CDC42BPA | 1.31525586 |
| 36 | SMG1 | 1.31386238 |
| 37 | HCK | 1.30741856 |
| 38 | CSK | 1.30083042 |
| 39 | TRIB3 | 1.28952791 |
| 40 | LCK | 1.28345564 |
| 41 | EEF2K | 1.25697022 |
| 42 | TAOK3 | 1.17505190 |
| 43 | ERN1 | 1.17059997 |
| 44 | MARK2 | 1.12009796 |
| 45 | SIK2 | 1.10804315 |
| 46 | IRAK1 | 1.07394846 |
| 47 | RIPK4 | 1.07085618 |
| 48 | RPS6KA4 | 1.06615170 |
| 49 | LRRK2 | 1.06387088 |
| 50 | MAPK11 | 1.02434298 |
| 51 | JAK2 | 1.02322325 |
| 52 | PTK6 | 1.01094211 |
| 53 | HIPK2 | 0.97647933 |
| 54 | TAOK1 | 0.96731168 |
| 55 | SIK1 | 0.94336901 |
| 56 | MAPK12 | 0.94152530 |
| 57 | SIK3 | 0.91960476 |
| 58 | TTN | 0.91422106 |
| 59 | MAPK7 | 0.91345996 |
| 60 | TRPM7 | 0.89994780 |
| 61 | NEK9 | 0.89780720 |
| 62 | PIM2 | 0.88900788 |
| 63 | MAP2K3 | 0.88070546 |
| 64 | PDK1 | 0.84820562 |
| 65 | ICK | 0.80731309 |
| 66 | PRKCQ | 0.79918339 |
| 67 | PDPK1 | 0.76124305 |
| 68 | LYN | 0.74664840 |
| 69 | TESK2 | 0.74368328 |
| 70 | KSR2 | 0.74284995 |
| 71 | TLK1 | 0.72867776 |
| 72 | MARK3 | 0.72606685 |
| 73 | MAP3K1 | 0.64794658 |
| 74 | FES | 0.64313018 |
| 75 | DMPK | 0.64244558 |
| 76 | FLT3 | 0.62114547 |
| 77 | PKN2 | 0.60169247 |
| 78 | MST4 | 0.56901248 |
| 79 | DYRK1B | 0.56698812 |
| 80 | MAPKAPK2 | 0.53669296 |
| 81 | CDK4 | 0.53597074 |
| 82 | RPS6KL1 | 0.53360183 |
| 83 | RPS6KC1 | 0.53360183 |
| 84 | IRAK2 | 0.53254778 |
| 85 | MAP3K7 | 0.52847410 |
| 86 | MELK | 0.52097911 |
| 87 | RPS6KA5 | 0.51883512 |
| 88 | SGK3 | 0.51562149 |
| 89 | CDK9 | 0.50990480 |
| 90 | MAP2K2 | 0.50882526 |
| 91 | STK38 | 0.50090406 |
| 92 | YES1 | 0.49508049 |
| 93 | RPS6KA2 | 0.48297586 |
| 94 | STK4 | 0.47658725 |
| 95 | PKN1 | 0.47189622 |
| 96 | CDK6 | 0.46294027 |
| 97 | CLK1 | 0.46274046 |
| 98 | CAMKK1 | 0.46166799 |
| 99 | TAOK2 | 0.45037519 |
| 100 | INSR | 0.43564128 |
| 101 | PDGFRB | 0.43241398 |
| 102 | PTK2B | 0.42478349 |
| 103 | FYN | 0.39728155 |
| 104 | PRKAA2 | 0.39674722 |
| 105 | ABL1 | 0.37675163 |
| 106 | BMX | 0.37362148 |
| 107 | PRKCH | 0.37258669 |
| 108 | MAP3K3 | 0.37127604 |
| 109 | EGFR | 0.37056745 |
| 110 | RAF1 | 0.36678726 |
| 111 | MAP3K9 | 0.36446629 |
| 112 | RPS6KA1 | 0.35013837 |
| 113 | SGK2 | 0.33644330 |
| 114 | TGFBR1 | 0.33155438 |
| 115 | ARAF | 0.33090959 |
| 116 | NUAK1 | 0.32891678 |
| 117 | CAMK1D | 0.31437251 |
| 118 | ALK | 0.31417118 |
| 119 | MTOR | 0.29979605 |
| 120 | TNK2 | 0.29250675 |
| 121 | PRKCI | 0.29194585 |
| 122 | PASK | 0.28618253 |
| 123 | MST1R | 0.28502041 |
| 124 | FGR | 0.27855324 |
| 125 | PRKCD | 0.27760954 |
| 126 | MAPK3 | 0.27727354 |
| 127 | RPS6KA6 | 0.27490600 |
| 128 | BRD4 | 0.26454950 |
| 129 | STK24 | 0.26017295 |
| 130 | GSK3A | 0.24606008 |
| 131 | PRKD2 | 0.22032489 |
| 132 | MATK | 0.21795504 |
| 133 | BMPR2 | 0.21476986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.33794238 |
| 2 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.17724657 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.70812134 |
| 4 | Measles_Homo sapiens_hsa05162 | 2.67041584 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.65962126 |
| 6 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.58918940 |
| 7 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.48475864 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.47225601 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.44901916 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.31430435 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.14703106 |
| 12 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.05609274 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.03940992 |
| 14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.03421636 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.02927184 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.98331895 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.97609496 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.92721766 |
| 19 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.84925615 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.78415002 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72503018 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68993729 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.68769254 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.65542291 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.59058291 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55975349 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.49269284 |
| 28 | * Apoptosis_Homo sapiens_hsa04210 | 1.47000770 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46977202 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46407151 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.43570492 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.42388461 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38745806 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.38503118 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33738200 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32462577 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32020552 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.29011379 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.26998336 |
| 40 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.21226534 |
| 41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19724776 |
| 42 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.16348025 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.14295652 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.13706648 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12123074 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.08854239 |
| 47 | * HTLV-I infection_Homo sapiens_hsa05166 | 1.05728735 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03805538 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00635207 |
| 50 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98948067 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96828167 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.90443864 |
| 53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.89404138 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.88154725 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.87111507 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.85531890 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84980217 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83656816 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83337503 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81787313 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79533096 |
| 62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77236362 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69555995 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67724305 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.63590575 |
| 66 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61669595 |
| 67 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61237771 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60169539 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57575048 |
| 70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56058640 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.54380349 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52714161 |
| 73 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.52522084 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52090763 |
| 75 | Prostate cancer_Homo sapiens_hsa05215 | 0.51429294 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.51151920 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50872398 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48593403 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46626402 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.46171811 |
| 81 | Pathways in cancer_Homo sapiens_hsa05200 | 0.45431422 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44819205 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44535040 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44244808 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44145109 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42874720 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42663375 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.41377915 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41133505 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.38947848 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37427343 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37248131 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36956337 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36723752 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36530767 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35816948 |
| 97 | Adherens junction_Homo sapiens_hsa04520 | 0.34309057 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33202344 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32683942 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32594911 |
| 101 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32324277 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.31470263 |
| 103 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28671205 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28341099 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28147354 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27738053 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26791781 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26208231 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26170185 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24555777 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23999029 |
| 112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23428707 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23208619 |
| 114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22845695 |
| 115 | Phagosome_Homo sapiens_hsa04145 | 0.21763375 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.19650988 |

